Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients

Transcription factor activating enhancer binding protein 4 (TFAP4) is an important regulator in the genesis and progression of human cancers. Overexpression of TFAP4 has been found to be correlated with several malignancies. The present study assessed the clinical importance of TFAP4 in colorectal cancer (CRC). First, immunohistochemistry was used to analyze TFAP4 expression and the association of TFAP4 expression with clinicopathological features on a tissue microarray containing 208 CRC patients. The results revealed that TFAP4 protein expression was significantly upregulated in CRC tissues compared with that in normal colon tissues (P<0.001). Of note, statistical analysis revealed that TFAP4 expression was significantly correlated with a high pathological grade (P=0.034), advanced clinical stage (P=0.024), enhanced tumor invasion (P=0.002) and lymph node metastasis (P=0.041). In addition, the Cancer Genome Atlas dataset further validated that TFAP4 mRNA levels were increased in CRC with advanced clinical stage (P=0.026), lymph node metastasis (P=0.018) and vascular invasion (P=0.046). Kaplan-Meier survival analysis demonstrated that CRC patients with high TFAP4 expression had shorter overall survival compared with those with low TFAP4 expression (P=0.011). Importantly, overexpression of TFAP4 was a valuable independent prognostic factor for CRC patients (hazard ratio, 8.200; 95% confidence interval, 1.838–36.591; P=0.006). In summary, TFAP4 may have an important role in CRC progression and upregulation of TFAP4 may be a predictor of poor prognosis for CRC patients.

[1]  F W MULSOW,et al.  Cancer incidence and mortality , 2019, Health at a Glance: Europe.

[2]  Jie He,et al.  Cancer incidence and mortality in China, 2013. , 2017, Cancer letters.

[3]  G. Perini,et al.  MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4 , 2016, Oncotarget.

[4]  W. Guo,et al.  Silencing of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human lung cancer cells. , 2016, Oncology letters.

[5]  Ping Yang,et al.  High expression of growth factor receptor-bound protein 14 predicts poor prognosis for colorectal cancer patients , 2016, Biotechnology Letters.

[6]  Xinxiang Li,et al.  High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma , 2015, Molecular Cancer.

[7]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[8]  Hui Zhao,et al.  AP‑4 predicts poor prognosis in non‑small cell lung cancer. , 2014, Molecular medicine reports.

[9]  Thomas Kirchner,et al.  AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer , 2013, The Journal of experimental medicine.

[10]  Ke Chen,et al.  High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy , 2012, Tumor Biology.

[11]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[12]  K. Tao,et al.  The overexpression of AP-4 as a prognostic indicator for gastric carcinoma , 2012, Medical Oncology.

[13]  Bo Zhang,et al.  Down-Regulation of AP-4 Inhibits Proliferation, Induces Cell Cycle Arrest and Promotes Apoptosis in Human Gastric Cancer Cells , 2012, PloS one.

[14]  G. Singaravelu,et al.  Identification and characterization of a putative basic helix-loop-helix (bHLH) transcription factor interacting with calcineurin in C. elegans , 2009, Molecules and cells.

[15]  Jie Cao,et al.  Upregulation of Activator Protein-4 in Human Colorectal Cancer With Metastasis , 2009, International journal of surgical pathology.

[16]  P. Jung,et al.  AP4 encodes a c-MYC-inducible repressor of p21 , 2008, Proceedings of the National Academy of Sciences.

[17]  R. Tjian,et al.  Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. , 1990, Genes & development.

[18]  R. Tjian,et al.  Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro , 1988, Nature.

[19]  H. Blottière,et al.  Impact of high-fat feeding on basic helix–loop–helix transcription factors controlling enteroendocrine cell differentiation , 2014, International Journal of Obesity.